Article Details

Discussion stirs around Sarepta Therapeutics, Inc. (NASDAQ:SRPT) this week; here is what ...

Retrieved on: 2019-01-06 22:48:45

Tags for this article:

Click the tags to see associated articles and topics

Discussion stirs around Sarepta Therapeutics, Inc. (NASDAQ:SRPT) this week; here is what .... View article details on hiswai:

Excerpt

<div><b>Benchmark Capital</b> Advsrs owns 4,000 shares for 0.49% of their portfolio. Since July 9, 2018, it had 2 insider purchases, and 3 insider sales for $11.97 ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo